Replies to post #13911 on Humanigen Inc (fka HGENQ)

[Fezziwig2008]

Since direct anti IL-6 monoclonal antibodies -Actemra and Kevzara- failed - all that’s left for COVID ARDS therapy is the anti GM-CSF monoclonal antibody - HGEN Lenzilumab - snooze and lose.

https://www.biorxiv.org/content/10.1101/2020.02.12.945576v1